Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Terminated 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Menorrhagia 7Leiomyoma 7Breast Neoplasms 7Polycystic Ovary Syndrome 3Hyperandrogenism 2Vaginitis 1Triple Negative Breast Neoplasms 1Sexual Dysfunction, Physiological 1Neoplasms 1Estrogen Levels Among Breast Cancer Patients 1Atrophic Vaginitis 1

Interventions

Metformin 14Clomiphene 6Progesterone 5Chorionic Gonadotropin 5drospirenone and ethinyl estradiol combination 4Sugars 4Letrozole 4Flutamide 4Estrogens 4Cholecalciferol 4follitropin alfa 3Pioglitazone 3Medroxyprogesterone Acetate 3Glycoprotein Hormones, alpha Subunit 3Estradiol 3Vitamin D 2Testosterone 2Resistance Training 2Raloxifene Hydrochloride 2Ovidrel 2Liraglutide 2Leuprolide 2Glucose Tolerance Test 2Exenatide 2Ethinyl Estradiol 2Contraceptives, Oral 2Continuous Positive Airway Pressure 2saxagliptin 1salicylsalicylic acid 1penclomedine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Polycystic Ovary Syndrome × Estradiol × Clear all
NCT01427595 2021-01-08

Effect of Metformin on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone

University of Virginia

Phase NA Completed
25 enrolled 6 charts

Polycystic Ovary Syndrome, Hyperandrogenism

NCT01428245 2020-12-30

JCM026

University of Virginia

Phase NA Terminated
3 enrolled 4 charts

Polycystic Ovary Syndrome

NCT01428193 2018-06-04

Effects of Androgen Blockade on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone

University of Virginia

Phase NA Terminated
4 enrolled 5 charts

Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡